Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nitric Oxide-releasing Medications and Colorectal Cancer Risk: The Framingham Study

JOSHUA E. MUSCAT, ANNE-MARIE DYER, RAPHAEL E. ROSENBAUM and BASIL RIGAS
Anticancer Research November 2005, 25 (6C) 4471-4474;
JOSHUA E. MUSCAT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNE-MARIE DYER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAPHAEL E. ROSENBAUM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BASIL RIGAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: basil.rigas{at}sunysb.edu
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4471-4474
PMID 
16334128

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 28, 2005
  • Accepted August 31, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. JOSHUA E. MUSCAT1,
  2. ANNE-MARIE DYER1,
  3. RAPHAEL E. ROSENBAUM2 and
  4. BASIL RIGAS2
  1. 1Department of Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA 17033
  2. 2Division of Cancer Prevention, Department of Medicine, SUNY at Stony Brook, Stony Brook, NY 11794-5200, U.S.A.
  1. Correspondence to: Basil Rigas, MD, D. Sc., Professor of Medicine, Chief, Division of Cancer Prevention, SUNY at Stony Brook, Life Sciences Building, Room 006, Stony Brook, NY 11794-5200, U.S.A. Tel: (631) 632-9035, Fax: (631) 632-1992, e-mail: basil.rigas{at}sunysb.edu

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nitric Oxide-releasing Medications and Colorectal Cancer Risk: The Framingham Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nitric Oxide-releasing Medications and Colorectal Cancer Risk: The Framingham Study
JOSHUA E. MUSCAT, ANNE-MARIE DYER, RAPHAEL E. ROSENBAUM, BASIL RIGAS
Anticancer Research Nov 2005, 25 (6C) 4471-4474;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nitric Oxide-releasing Medications and Colorectal Cancer Risk: The Framingham Study
JOSHUA E. MUSCAT, ANNE-MARIE DYER, RAPHAEL E. ROSENBAUM, BASIL RIGAS
Anticancer Research Nov 2005, 25 (6C) 4471-4474;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Alpha-Blockers As Colorectal Cancer Chemopreventive: Findings from a Case-Control Study, Human Cell Cultures, and In Vivo Preclinical Testing
  • Novel agents for cancer prevention based on nitric oxide
  • Google Scholar

More in this TOC Section

  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
  • Prognostic and Neurological Outcomes Following Surgery for Spinal NF2-Associated Ependymomas With Cysts
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire